Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

Related Citations for PubMed (Select 24710679)

1.

[MAO-inhibitors--a treatment option for treatment resistant depression: application, efficacy and characteristics].

Köhler S, Stöver LA, Bschor T.

Fortschr Neurol Psychiatr. 2014 Apr;82(4):228-36; quiz 237-8. doi: 10.1055/s-0034-1365945. Epub 2014 Apr 7. Review. German. No abstract available.

PMID:
24710679
2.

Introduction: a fresh look at monoamine oxidase inhibitors for depression.

Cohen LJ, Sclar DA.

J Clin Psychiatry. 2012;73 Suppl 1:3-4. doi: 10.4088/JCP.11096su1c.00. No abstract available.

PMID:
22951235
3.

Discussion: a fresh look at monoamine oxidase inhibitors for depression.

Cohen LJ, Sclar DA, Culpepper L, Flockhart DA, Hirschfeld RM, Thase ME, VanDenBerg CM.

J Clin Psychiatry. 2012;73 Suppl 1:42-5. doi: 10.4088/JCP.11096su1c.07. No abstract available.

PMID:
22951242
4.

Current place of monoamine oxidase inhibitors in the treatment of depression.

Shulman KI, Herrmann N, Walker SE.

CNS Drugs. 2013 Oct;27(10):789-97. doi: 10.1007/s40263-013-0097-3. Review.

PMID:
23934742
5.

Reversible monoamine oxidase-A inhibitors in resistant major depression.

Nolen WA, Hoencamp E, Bouvy PF, Haffmans PM.

Clin Neuropharmacol. 1993;16 Suppl 2:S69-76. Review.

PMID:
8313400
6.

N-acetylcysteine augmentation to tranylcypromine in treatment-resistant major depression.

Carvalho AF, Macêdo DS, Goulia P, Hyphantis TN.

J Clin Psychopharmacol. 2013 Oct;33(5):719-20. doi: 10.1097/JCP.0b013e31829839c6. No abstract available.

PMID:
23899640
7.

Monoamine oxidase inhibitors revisited: what you should know.

Goldberg JF, Thase ME.

J Clin Psychiatry. 2013 Feb;74(2):189-91. doi: 10.4088/JCP.12ac08299. No abstract available.

PMID:
23473352
8.

[Moclobemide].

Gleiter C, Volz HP.

Dtsch Med Wochenschr. 1995 Aug 25;120(34-35):1175-6. German. No abstract available.

PMID:
7656852
9.

MAOIs and depression treatment guidelines.

Thase ME.

J Clin Psychiatry. 2012 Jul;73(7):e24. doi: 10.4088/JCP.11096tx4c.

PMID:
22901357
10.

STAR*D: a summary and UK perspective.

Deakin J, O'Loughlin C.

J Psychopharmacol. 2009 Aug;23(6):605-12. doi: 10.1177/0269881109104886. Epub 2009 Apr 24. Review. No abstract available.

PMID:
19395428
11.

Dietary restrictions and drug interactions with monoamine oxidase inhibitors: an update.

Flockhart DA.

J Clin Psychiatry. 2012;73 Suppl 1:17-24. doi: 10.4088/JCP.11096su1c.03. Review.

PMID:
22951238
12.

The use of monoamine oxidase inhibitors in primary care.

Culpepper L.

J Clin Psychiatry. 2012;73 Suppl 1:37-41. doi: 10.4088/JCP.11096su1c.06. Review.

PMID:
22951241
13.

[Monoamine oxidase inhibitors in psychiatry. Status of current knowledge].

Volz HP, Gleiter CH, Möller HJ.

Nervenarzt. 1996 May;67(5):339-47. Review. German.

PMID:
9005342
14.

The role of monoamine oxidase inhibitors in depression treatment guidelines.

Thase ME.

J Clin Psychiatry. 2012;73 Suppl 1:10-6. doi: 10.4088/JCP.11096su1c.02.

PMID:
22951237
15.

Issues in adherence to treatment with monoamine oxidase inhibitors and the rate of treatment failure.

Cohen LJ, Sclar DA.

J Clin Psychiatry. 2012;73 Suppl 1:31-6. doi: 10.4088/JCP.11096su1c.05. Review.

PMID:
22951240
16.
17.

Efficacy of reversible inhibitors of monoamine oxidase-A in various forms of depression.

Lecrubier Y, Guelfi JD.

Acta Psychiatr Scand Suppl. 1990;360:18-23.

PMID:
2248063
18.

MAO inhibitors: risks, benefits, and lore.

Wimbiscus M, Kostenko O, Malone D.

Cleve Clin J Med. 2010 Dec;77(12):859-82. doi: 10.3949/ccjm.77a.09103. Review.

PMID:
21147941
19.

Safety of high-intensity treatment with the irreversible monoamine oxidase inhibitor tranylcypromine in patients with treatment-resistant depression.

Adli M, Pilhatsch M, Bauer M, Köberle U, Ricken R, Janssen G, Ulrich S, Bschor T.

Pharmacopsychiatry. 2008 Nov;41(6):252-7. doi: 10.1055/s-0028-1083819. Epub 2008 Dec 9. Erratum in: Pharmacopsychiatry. 2009 Jan;42(1):39.

PMID:
19067263
20.

Psychopharmacology column: why choose selegiline transdermal system for refractory depression?

Tobin M.

Issues Ment Health Nurs. 2007 Feb;28(2):223-8. No abstract available.

PMID:
17365170
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk